Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study

Jared Silver, Elizabeth Packnett, Julie Park, Arijita Deb · 2023

Read Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study by Jared Silver, Elizabeth Packnett, Julie Park, Arijita Deb (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10709958.txt.

Description

Jared Silver and three co-authors map how biologic drugs are used for a stubborn sinus condition in the United States, in a 2023 claims study. The condition pairs long-term sinus inflammation with nasal polyps. Several biologics are approved as add-on care. The team used a large insurance claims database to find nearly six thousand adults with the condition. They tracked care over about two years and compared users and non-users of the drugs.

About one in ten patients used a biologic in the follow-up year. Users were far more likely to have asthma, which alone raised the odds more than fivefold. Steroid pill use was also higher among users. Most surgery patients who used a biologic started it before their operation. The authors say the pattern marks patients with high unmet need. Such signs could help clinics spot good candidates sooner.

Catalog record

CREATORJared Silver, Elizabeth Packnett, Julie Park, Arijita Deb
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10709958

Browse the full library · About the Tower of Babel